# GPATCH2

## Overview
GPATCH2 is a gene that encodes the protein G-patch domain containing 2, which is characterized by the presence of a G-patch domain known for its role in RNA binding and processing. This protein is involved in the regulation of RNA helicases, particularly through its interaction with the RNA helicase DHX15, which is crucial for RNA remodeling activities such as pre-mRNA splicing and ribosome biogenesis (Memet2024Insights; Bohnsack2021Regulation). GPATCH2 is predominantly localized in the nucleoplasm and nucleoli, indicating its involvement in ribosome biogenesis (Memet2024Insights). The protein's interaction with DHX15 suggests a significant role in RNA metabolism and gene expression regulation, although its specific functions in alternative splicing or other cellular processes remain to be fully elucidated (Memet2024Insights). GPATCH2 has been implicated in various diseases, including cancer, where it is overexpressed in breast cancer cell lines, suggesting its potential as a therapeutic target (Kanwal2024Analysis; Memet2024Insights). Further research is necessary to fully understand the diverse roles of GPATCH2 in cellular processes and disease pathogenesis.

## Structure
The GPATCH2 protein is characterized by the presence of a G-patch domain, which is involved in RNA binding and processing. The primary structure of GPATCH2 consists of a sequence of amino acids that form the basis for its functional properties. The secondary structure of the protein may include elements such as alpha helices and beta sheets, which contribute to its stability and function. The tertiary structure refers to the overall three-dimensional shape of the protein, which is crucial for its interaction with RNA and other molecules. While the quaternary structure involves the assembly of multiple protein subunits, it is not specified whether GPATCH2 forms such complexes.

Post-translational modifications, such as phosphorylation, may occur in GPATCH2, potentially influencing its activity and interactions. The existence of splice variant isoforms of GPATCH2 suggests that different forms of the protein may have distinct functions, allowing for a range of biological roles. These structural features and modifications are essential for the protein's involvement in RNA processing and its broader biological functions.

## Function
GPATCH2 is a protein involved in RNA processing, particularly in the regulation of RNA helicases, which are crucial for RNA remodeling activities such as pre-mRNA splicing and ribosome biogenesis. It is known to interact with the RNA helicase DHX15, stimulating its ATPase activity, which is essential for its function in RNA processing pathways (Memet2024Insights; Bohnsack2021Regulation). GPATCH2 is localized in the nucleoplasm and nucleoli, suggesting its involvement in ribosome biogenesis, as these are key sites for ribosome production (Memet2024Insights).

The protein's interaction with DHX15 indicates a role in RNA metabolism and gene expression regulation, although its specific functions in alternative splicing or other cellular processes remain unclear (Memet2024Insights). GPATCH2's nucleolar enrichment and its similarity to yeast homologs, which are implicated in ribosome production, further support its role in ribosome biogenesis (Memet2024Insights). Despite its involvement in these critical cellular processes, the full range of GPATCH2's functions in healthy human cells is not yet fully understood, highlighting the need for further research (Memet2024Insights).

## Clinical Significance
GPATCH2 has been implicated in various diseases, particularly in cancer. It is notably overexpressed in breast cancer cell lines, where it interacts with the RNA helicase DHX15. This interaction is thought to stimulate DHX15 activity, potentially leading to hyperactive ribosome biogenesis and promoting cancer cell proliferation (Kanwal2024Analysis; Memet2024Insights). The overexpression of GPATCH2 in breast cancer suggests a role in tumorigenesis, making it a potential target for therapeutic intervention.

In addition to its role in cancer, GPATCH2 has been identified as having potential pathogenic variants in patients with Rett syndrome-like symptoms. In one case, a variant in GPATCH2 was found alongside other genetic mutations, although the specific contribution of GPATCH2 to the phenotype was not fully detailed (Lucariello2016Whole).

While the specific mechanisms by which GPATCH2 contributes to these diseases are not entirely understood, its involvement in RNA processing and interaction with RNA helicases like DHX15 highlights its potential significance in disease pathogenesis. Further research is needed to elucidate the precise role of GPATCH2 in these conditions and its potential as a biomarker or therapeutic target.

## Interactions
GPATCH2 is known to interact with the RNA helicase DHX15, forming a complex that may regulate the helicase's activity. This interaction is particularly significant as GPATCH2 shows a 21.9-fold enrichment with DHX15 compared to controls, indicating a strong association (Memet2024Insights). The GPATCH2-DHX15 complex is suggested to play a role in ribosome biogenesis and is implicated in cancer cell proliferation due to its hyperactivation of DHX15, which is overexpressed in breast cancer (Kanwal2024Analysis; Memet2024Insights).

While specific interactions of GPATCH2 with nucleic acids are not detailed, the G-patch domain, characteristic of GPATCH2, is known for its RNA binding capabilities. This domain facilitates interactions with helicases by inserting conserved hydrophobic/aromatic sidechains into helicase surfaces, stabilizing them in a conformation with high RNA affinity and activating their ATPase and helicase activities (Bohnsack2021Regulation). GPATCH2, like other G-patch proteins, may compete for binding to helicases, directing them to various cellular pathways (Rathje2024Analysis). However, specific details about GPATCH2's interactions with other proteins or nucleic acids beyond DHX15 are not provided in the available context.


## References


1. (Rathje2024Analysis) Analysis of Expression of RNA Helicases and Cofactors in Human Tissues and Cancer. This article has 0 citations.

[2. (Bohnsack2021Regulation) Katherine E. Bohnsack, Ralf Ficner, Markus T. Bohnsack, and Stefanie Jonas. Regulation of deah-box rna helicases by g-patch proteins. Biological Chemistry, 402(5):561–579, January 2021. URL: http://dx.doi.org/10.1515/hsz-2020-0338, doi:10.1515/hsz-2020-0338. This article has 44 citations and is from a peer-reviewed journal.](https://doi.org/10.1515/hsz-2020-0338)

[3. (Lucariello2016Whole) Mario Lucariello, Enrique Vidal, Silvia Vidal, Mauricio Saez, Laura Roa, Dori Huertas, Mercè Pineda, Esther Dalfó, Joaquin Dopazo, Paola Jurado, Judith Armstrong, and Manel Esteller. Whole exome sequencing of rett syndrome-like patients reveals the mutational diversity of the clinical phenotype. Human Genetics, 135(12):1343–1354, August 2016. URL: http://dx.doi.org/10.1007/s00439-016-1721-3, doi:10.1007/s00439-016-1721-3. This article has 57 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00439-016-1721-3)

4. (Memet2024Insights) Insights into the regulation of RNA helicases by protein cofactors. This article has 0 citations.

5. (Kanwal2024Analysis) Analysis of multifunctional RNA helicase regulation by protein cofactors in different gene expression processes. This article has 0 citations.